Wikidata

(Q39262037)

English

Randomized phase II trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate cancer progressing after first-line docetaxel: CUOG trial P-06c.

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

title
Randomized phase II trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate cancer progressing after first-line docetaxel: CUOG trial P-06c (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21788353
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21788353%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39262037&oldid=1966860020"